Investigating a protein's role in heart failure and cardiac remodeling
RECK in Adverse Cardiac Remodeling and Heart Failure
This study is looking at how a protein called RECK affects heart failure in older adults and whether changing its levels can help improve heart function and keep patients out of the hospital.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harry S. Truman Memorial VA Hospital NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10911046 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific protein, RECK, influences heart failure and adverse cardiac remodeling in older adults. It examines the mechanisms by which RECK inhibits harmful processes in the heart, particularly those triggered by hypertension and aortic valve stenosis. The study aims to explore how manipulating RECK levels could potentially improve heart function and reduce hospital readmissions for heart failure patients. By analyzing both in vivo and in vitro models, the research seeks to uncover new therapeutic strategies for managing heart failure.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those over 65, who are experiencing heart failure or related cardiac issues.
Not a fit: Patients under 65 years of age or those without heart failure or significant cardiac conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve heart health and reduce hospitalizations for older patients with heart failure.
How similar studies have performed: Previous research has shown promising results in targeting similar pathways for heart failure treatment, indicating potential for success in this approach.
Where this research is happening
Columbia, United States
- Harry S. Truman Memorial VA Hospital — Columbia, United States (Active)
Researchers
- Principal investigator: Bysani, Chandrasekar — Harry S. Truman Memorial VA Hospital
- Study coordinator: Bysani, Chandrasekar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.